Over 75s with RCC represent unique subpopulation
Older adults with metastatic renal cell carcinoma are less likely to receive treatment, and have a poorer outcome than their younger peers, research suggests. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 23, 2013 Category: Cancer & Oncology Source Type: news
Laparoscopy viable for local RCC relapse
Laparoscopic treatment of local relapse of renal cell carcinoma is a viable alternative to open surgery in selected cases, study findings show. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 22, 2013 Category: Cancer & Oncology Source Type: news
History of statin use lowers prostate cancer mortality
Research shows that men with prostate cancer have a significantly reduced risk for death if they took statins prior to their diagnosis. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 14, 2013 Category: Cancer & Oncology Source Type: news
Excess deaths among seminoma patients persist
US research shows that men diagnosed with stage I seminoma since the advent of contemporary radiotherapy have a significantly increased risk for all-cause mortality compared with the overall population, despite being unlikely to die from testicular cancer itself. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 13, 2013 Category: Cancer & Oncology Source Type: news
Thalidomide fails to boost mesothelioma outcomes
Adding maintenance thalidomide to standard first-line chemotherapy does not improve outcomes among patients with malignant pleural or peritoneal mesothelioma, study findings indicate. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 10, 2013 Category: Cancer & Oncology Source Type: news
Burden of symptoms could guide NSCLC pemetrexed use
Symptom burden and performance status may help identify the patients with non-squamous non-small-cell lung cancer who are likely to respond to maintenance pemetrexed therapy, phase III trial findings suggest. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
KRAS oncogene substitutions may be predictive in lung adenocarcinoma
Researchers have found that certain KRAS oncogene substitutions may have predictive value in lung adenocarcinoma. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
TKI resistance markers found for NSCLC patients
Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
Hsp90 inhibitor shows NSCLC promise
Treatment with a heatshock protein 90 inhibitor may induce loss of EML4-AKL expression in non-small cell lung cancer cells, preliminary results suggest. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
Gene fusion reduces NSCLC patient survival
ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
S-1 combination regimen effective for NSCLC
Researchers suggest that combined therapy with the fluoropyrimidine S-1, carboplatin, and bevacizumab followed by maintenance therapy with S-1 and bevacizumab should be first-line treatment for patients with advanced non-squamous non-small-cell lung cancer. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 8, 2013 Category: Cancer & Oncology Source Type: news
Active surveillance encouraged for very-low-risk prostate cancer in under 55s
A study of US servicemen shows that, despite being eligible for active surveillance, the overwhelming majority of young men diagnosed with very-low-risk prostate cancer opt for immediate treatment. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 6, 2013 Category: Cancer & Oncology Source Type: news
‘Liquid biopsy’ continues to show promise in prostate cancer
Study results add further support to the use of circulating tumor cells as an effective prognostic marker in prostate cancer, and suggest that they could be used to monitor metastatic disease progression. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 5, 2013 Category: Cancer & Oncology Source Type: news
New guidance on radioiodine therapy use after radiographic studies
Researchers have provided new evidence that could act as a guide for the use of radioiodine therapy after patients have undergone radiographic imaging studies that use iodine as a contrasting agent. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - May 1, 2013 Category: Cancer & Oncology Source Type: news
New risk classification system proposed for prostate cancer
US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - April 29, 2013 Category: Cancer & Oncology Source Type: news
